{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-026375","form_type":"8-K","ticker":"SMTI","cik":"0000714256","company_name":"Sanara MedTech Inc.","filed_at":"2023-08-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.470282+00:00","generated_at":"2026-06-12T15:27:28.889701+00:00","sec_items":["1.01","2.01","2.03","3.02","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Sanara MedTech acquires collagen assets for $15.25M; funds with $12M loan from Cadence Bank","bullets":["Acquired IP, manufacturing rights, and four 510(k)-cleared products including CellerateRX and HYCOL.","Purchase price: $9.75M cash, $3.0M in stock (73,809 shares), $2.5M in four annual installments.","Entered $12M term loan with Cadence Bank at Term SOFR + 3%, maturing August 2028.","Sellers eligible for up to $10M earnout based on future sales of a collagen product under development."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-026375","json":"https://secwatch.observer/filing/0001493152-23-026375.json","markdown":"https://secwatch.observer/filing/0001493152-23-026375.md","text":"https://secwatch.observer/filing/0001493152-23-026375.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/714256/000149315223026375/0001493152-23-026375-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/714256/000149315223026375/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T15:27:28.889701+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e0322ec85f36a78a749e6fe7aa8b7618eac35e5f","claim":"Sanara MedTech Inc. completed an acquisition involving The Hymed Group Corporation and Applied Nutritionals, LLC for $15.25 million (closed 2023-08-01).","evidence_excerpt":"HYCOL Hydrolyzed Collagen (Powder and Gel) (“HYCOL”) products for human wound care use. The Purchased Assets were purchased for an initial aggregate purchase price of $15.25 million, consisting of (i) $9.75 million in cash (the “Cash Closing Consideration”), (ii) 73,809 shares of the Company’s common stock, par value $0.001 per share (the “Stock Closing","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/714256/000149315223026375/0001493152-23-026375-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"acquisition"},{"label":"Counterparty","value":"The Hymed Group Corporation and Applied Nutritionals, LLC"},{"label":"Consideration","value":"$15.25 million"},{"label":"Closing","value":"2023-08-01"}],"fact_type":"ma_transaction"},{"claim_id":"34298b0cd75c1d4843a5c8f6fcb02fcf53ae942e","claim":"Sanara MedTech Inc. entered into Asset Purchase Agreement with The Hymed Group Corporation, Applied Nutritionals, LLC, and Dr. George D. Petito valued at initial aggregate purchase price of $15.25 million (effective 2023-08-01).","evidence_excerpt":"On August 1, 2023, Sanara MedTech Inc., a Texas corporation (the “Company”), entered into an Asset Purchase Agreement (the “Purchase Agreement”) by and among the Company, as guarantor, Sanara MedTech Applied Technologies, LLC, a Texas limited liability company and wholly owned subsidiary of the Company (the “Purchaser”), The Hymed Group Corporation, a Delaware corporation (“Hymed”), Applied Nutritionals, LLC, a Delaware limited liability company (“Applied” and, together with Hymed, the “Sellers”), and Dr. George D. Petito (the “Owner”)","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/714256/000149315223026375/0001493152-23-026375-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"The Hymed Group Corporation, Applied Nutritionals, LLC, and Dr. George D. Petito"},{"label":"Value","value":"initial aggregate purchase price of $15.25 million"},{"label":"Effective","value":"2023-08-01"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}